We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Abbott to Market Mad Cow Tests for Cattle

By Labmedica staff writers
Posted on 29 Mar 2001
Abbott Laboratories (Abbott Park, IL, USA) has entered into an agreement with Enfer Scientific Ltd. More...
(Tipperary, Ireland) for the marketing and distribution of two diagnostic tests developed by Enfer to detect bovine encephalopathy (BSE), or mad cow disease, in cattle. Abbott will market the tests under the Enfer name.

The tests detect the presence of the abnormal prion protein associated with BSE. One test is a four-hour enzyme-linked immunosorbent assay (ELISA), approved by the European Commission. The test's rapid turnaround time and high throughput capabilities make it well suited for testing for mad cow disease. The second test is a supplemental diagnostic test used to confirm positive results of the first test. Both tests are conducted on brain tissue and spinal cord samples from cattle.

"We believe we have two very effective tests that improve the speed and reliability of BSE testing,” said Louis Ronan, director of Enfer Scientific. "By helping to ensure that only BSE-free meat enters the human food chain, these tests are making an important contribution to public safety.”




Related Links:
Abbott Diagnostics

New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Immobilization System
Cranial 4Pi Immobilization
New
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.